MIRA Pharmaceuticals (MIRA) Competitors $1.73 -0.01 (-0.57%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$1.74 +0.01 (+0.58%) As of 07/25/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MIRA vs. ANIX, COYA, CRBP, HURA, MGNX, ZNTL, OPTN, WHWK, CTNM, and CLYMShould you be buying MIRA Pharmaceuticals stock or one of its competitors? The main competitors of MIRA Pharmaceuticals include Anixa Biosciences (ANIX), Coya Therapeutics (COYA), Corbus Pharmaceuticals (CRBP), TuHURA Biosciences (HURA), MacroGenics (MGNX), Zentalis Pharmaceuticals (ZNTL), OptiNose (OPTN), Whitehawk Therapeutics (WHWK), Contineum Therapeutics (CTNM), and Climb Bio (CLYM). These companies are all part of the "pharmaceutical products" industry. MIRA Pharmaceuticals vs. Its Competitors Anixa Biosciences Coya Therapeutics Corbus Pharmaceuticals TuHURA Biosciences MacroGenics Zentalis Pharmaceuticals OptiNose Whitehawk Therapeutics Contineum Therapeutics Climb Bio Anixa Biosciences (NASDAQ:ANIX) and MIRA Pharmaceuticals (NASDAQ:MIRA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations. Do analysts prefer ANIX or MIRA? Anixa Biosciences currently has a consensus price target of $9.00, suggesting a potential upside of 179.50%. MIRA Pharmaceuticals has a consensus price target of $14.00, suggesting a potential upside of 709.25%. Given MIRA Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe MIRA Pharmaceuticals is more favorable than Anixa Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anixa Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25MIRA Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Do insiders and institutionals hold more shares of ANIX or MIRA? 29.1% of Anixa Biosciences shares are owned by institutional investors. Comparatively, 35.2% of MIRA Pharmaceuticals shares are owned by institutional investors. 25.3% of Anixa Biosciences shares are owned by company insiders. Comparatively, 6.7% of MIRA Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media refer more to ANIX or MIRA? In the previous week, Anixa Biosciences had 4 more articles in the media than MIRA Pharmaceuticals. MarketBeat recorded 5 mentions for Anixa Biosciences and 1 mentions for MIRA Pharmaceuticals. MIRA Pharmaceuticals' average media sentiment score of 1.87 beat Anixa Biosciences' score of 1.27 indicating that MIRA Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Anixa Biosciences Positive MIRA Pharmaceuticals Very Positive Is ANIX or MIRA more profitable? Anixa Biosciences' return on equity of -68.17% beat MIRA Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Anixa BiosciencesN/A -68.17% -60.38% MIRA Pharmaceuticals N/A -341.08%-272.93% Which has preferable earnings and valuation, ANIX or MIRA? Anixa Biosciences is trading at a lower price-to-earnings ratio than MIRA Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnixa BiosciencesN/AN/A-$12.55M-$0.38-8.47MIRA PharmaceuticalsN/AN/A-$7.85M-$0.51-3.39 Which has more risk and volatility, ANIX or MIRA? Anixa Biosciences has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, MIRA Pharmaceuticals has a beta of 1.72, indicating that its stock price is 72% more volatile than the S&P 500. SummaryMIRA Pharmaceuticals beats Anixa Biosciences on 7 of the 13 factors compared between the two stocks. Get MIRA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MIRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MIRA vs. The Competition Export to ExcelMetricMIRA PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$29.44M$3.07B$5.70B$9.50BDividend YieldN/A2.37%4.60%4.01%P/E Ratio-3.3921.1828.1020.05Price / SalesN/A286.99429.3789.38Price / CashN/A42.7636.2258.56Price / Book13.318.378.665.87Net Income-$7.85M-$55.19M$3.25B$258.55M7 Day Performance-3.89%5.88%4.22%3.73%1 Month Performance42.98%17.33%10.51%11.75%1 Year Performance-36.16%4.42%34.40%18.03% MIRA Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MIRAMIRA Pharmaceuticals2.5933 of 5 stars$1.73-0.6%$14.00+709.2%-43.1%$29.44MN/A-3.392Positive NewsGap UpANIXAnixa Biosciences3.0898 of 5 stars$3.20+1.9%$9.00+181.3%+11.4%$103.07M$210K-8.425COYACoya Therapeutics1.9053 of 5 stars$6.16+0.5%$16.50+167.9%-9.4%$103.03M$3.69M-5.766News CoverageAnalyst ForecastCRBPCorbus Pharmaceuticals4.7901 of 5 stars$8.36+1.1%$50.88+508.6%-83.3%$102.33MN/A-1.9840HURATuHURA Biosciences1.7792 of 5 stars$2.33+1.3%$12.67+443.6%N/A$101.77MN/A0.00N/AMGNXMacroGenics4.4323 of 5 stars$1.58-1.9%$5.71+261.7%-68.9%$99.68M$152.43M-1.78430News CoverageZNTLZentalis Pharmaceuticals2.3173 of 5 stars$1.36+2.3%$8.37+515.2%-66.3%$97.85M$67.43M-0.43160News CoverageOPTNOptiNose0.6383 of 5 stars$9.60flat$9.00-6.3%N/A$97.22M$81.86M-2.29190WHWKWhitehawk TherapeuticsN/A$2.05+7.3%N/AN/A$96.57M$27.78M12.8140CTNMContineum Therapeutics3.3702 of 5 stars$3.73-4.8%$22.50+503.2%-72.6%$96.50M$50M-1.8931CLYMClimb Bio3.3682 of 5 stars$1.42+3.6%$9.00+533.8%N/A$95.96MN/A-0.609 Related Companies and Tools Related Companies Anixa Biosciences Competitors Coya Therapeutics Competitors Corbus Pharmaceuticals Competitors TuHURA Biosciences Competitors MacroGenics Competitors Zentalis Pharmaceuticals Competitors OptiNose Competitors Whitehawk Therapeutics Competitors Contineum Therapeutics Competitors Climb Bio Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MIRA) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhat I told my neighbor to do with his moneyWhen a close friend inherited money, Joel Litman gave him the same investment advice he gives his own mom. ...Altimetry | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MIRA Stock Alerts